{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:55:13Z","timestamp":1790787313783,"version":"4.1.0"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.biopha.2025.118100","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T06:44:13Z","timestamp":1745909053000},"page":"118100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["SARS-CoV-2 S1 protein induces IgG-mediated platelet activation and is prevented by 1.8-cineole"],"prefix":"10.1016","volume":"187","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6760-2149","authenticated-orcid":false,"given":"Julie","family":"Petry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1182-4975","authenticated-orcid":false,"given":"Maria","family":"Shoykhet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Weiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Griesbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Bashiri Dezfouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Admar","family":"Verschoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Wollenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118100_bib1","unstructured":"W. H. Organization (2024) WHO COVID-19 dashboard. (World Health Organization)."},{"key":"10.1016\/j.biopha.2025.118100_bib2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2025.118100_bib3","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1161\/CIRCULATIONAHA.120.048488","article-title":"Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy","volume":"142","author":"Nicolai","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2025.118100_bib4","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study","volume":"46","author":"Helms","year":"2020","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.biopha.2025.118100_bib5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1182\/blood.2020006520","article-title":"COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection","volume":"136","author":"Al-Samkari","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2025.118100_bib6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cca.2020.03.022","article-title":"Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis","volume":"506","author":"Lippi","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.biopha.2025.118100_bib7","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1111\/bjh.16817","article-title":"The association between severe COVID-19 and low platelet count: evidence from 31 observational studies involving 7613 participants","volume":"190","author":"Jiang","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.biopha.2025.118100_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000512007","article-title":"The impact of COVID-19 disease on platelets and coagulation","volume":"88","author":"Wool","year":"2021","journal-title":"Pathobiology"},{"key":"10.1016\/j.biopha.2025.118100_bib9","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00428-020-02926-1","article-title":"Increased number of pulmonary megakaryocytes in COVID-19 patients with diffuse alveolar damage: an autopsy study with clinical correlation and review of the literature","volume":"478","author":"Valdivia-Mazeyra","year":"2021","journal-title":"Virchows Arch."},{"key":"10.1016\/j.biopha.2025.118100_bib10","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1182\/blood.2020007214","article-title":"Platelet gene expression and function in patients with COVID-19","volume":"136","author":"Manne","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2025.118100_bib11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41419-020-03333-9","article-title":"SARS-CoV-2 infection is associated with a pro-thrombotic platelet phenotype","volume":"12","author":"Bongiovanni","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2025.118100_bib12","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1161\/CIRCRESAHA.120.317803","article-title":"Platelet and vascular biomarkers associate with thrombosis and death in coronavirus disease","volume":"127","author":"Barrett","year":"2020","journal-title":"Circ. Res"},{"key":"10.1016\/j.biopha.2025.118100_bib13","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1080\/09537104.2020.1754383","article-title":"Association between platelet parameters and mortality in coronavirus disease 2019: retrospective cohort study","volume":"31","author":"Liu","year":"2020","journal-title":"Platelets"},{"key":"10.1016\/j.biopha.2025.118100_bib14","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1440-1711.2005.01314.x","article-title":"Evidence of Toll-like receptor molecules on human platelets","volume":"83","author":"Cognasse","year":"2005","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118100_bib15","doi-asserted-by":"crossref","first-page":"8951","DOI":"10.1128\/JVI.00136-06","article-title":"DC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by platelets","volume":"80","author":"Chaipan","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2025.118100_bib16","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/CIRCULATIONAHA.114.013743","article-title":"Nucleotide-binding oligomerization domain 2 receptor is expressed in platelets and enhances platelet activation and thrombosis","volume":"131","author":"Zhang","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2025.118100_bib17","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1182\/blood.V60.6.1277.1277","article-title":"Characterization of the IgG-Fc receptor on human platelets","volume":"60","author":"Karas","year":"1982","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2025.118100_bib18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an intravascular effector of innate immunity","volume":"13","author":"Engelmann","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2025.118100_bib19","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nri2956","article-title":"Platelets and the immune continuum","volume":"11","author":"Semple","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2025.118100_bib20","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41569-021-00552-1","article-title":"Interplay between inflammation and thrombosis in cardiovascular pathology","volume":"18","author":"Stark","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2025.118100_bib21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41577-023-00834-4","article-title":"The role of platelets in immune-mediated inflammatory diseases","volume":"23","author":"Scherlinger","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2025.118100_bib22","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/jth.12178","article-title":"Dengue induces platelet activation, mitochondrial dysfunction and cell death through mechanisms that involve DC-SIGN and caspases","volume":"11","author":"Hottz","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.biopha.2025.118100_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007625","article-title":"Dengue virus nonstructural protein 1 activates platelets via Toll-like receptor 4, leading to thrombocytopenia and hemorrhage","volume":"15","author":"Chao","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.biopha.2025.118100_bib24","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/s41467-019-09607-x","article-title":"The role of platelets in mediating a response to human influenza infection","volume":"10","author":"Koupenova","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.118100_bib25","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/jth.13226","article-title":"Escherichia coli induces platelet aggregation in an FcgammaRIIa-dependent manner","volume":"14","author":"Moriarty","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.biopha.2025.118100_bib26","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1182\/blood-2013-07-515536","article-title":"Influenza virus H1N1 activates platelets through FcgammaRIIA signaling and thrombin generation","volume":"123","author":"Boilard","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2025.118100_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002355","article-title":"Novel anti-bacterial activities of \u03b2-defensin 1 in human platelets: suppression of pathogen growth and signaling of neutrophil extracellular trap formation","volume":"7","author":"Kraemer","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.biopha.2025.118100_bib28","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1182\/bloodadvances.2017011817","article-title":"Platelet HMGB1 is required for efficient bacterial clearance in intra-abdominal bacterial sepsis in mice","volume":"2","author":"Zhou","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.biopha.2025.118100_bib29","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13045-020-00954-7","article-title":"SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19","volume":"13","author":"Zhang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2025.118100_bib30","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.120.317703","article-title":"Platelets Can Associate with SARS-Cov-2 RNA and Are Hyperactivated in COVID-19","author":"Zaid","year":"2020","journal-title":"Circ. Res"},{"key":"10.1016\/j.biopha.2025.118100_bib31","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1161\/CIRCRESAHA.121.319117","article-title":"SARS-CoV-2 Initiates Programmed Cell Death in Platelets","volume":"129","author":"Koupenova","year":"2021","journal-title":"Circ. Res"},{"key":"10.1016\/j.biopha.2025.118100_bib32","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1161\/CIRCRESAHA.122.321541","article-title":"Toll-Like Receptor 4-Dependent Platelet-Related Thrombosis in SARS-CoV-2 Infection","volume":"132","author":"Carnevale","year":"2023","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2025.118100_bib33","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150101","article-title":"Platelets mediate inflammatory monocyte activation by SARS-CoV-2 spike protein","volume":"132","author":"Li","year":"2022","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.biopha.2025.118100_bib34","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/jth.15575","article-title":"Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19","volume":"20","author":"Maugeri","year":"2022","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.biopha.2025.118100_bib35","article-title":"SARS-CoV-2 Spike protein activates TMEM16F-mediated platelet procoagulant activity","volume":"9","author":"Cappelletto","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.biopha.2025.118100_bib36","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1055\/s-0041-1733934","article-title":"Platelet surface protein expression and reactivity upon TRAP stimulation after BNT162b2 vaccination","volume":"122","author":"Klug","year":"2022","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.biopha.2025.118100_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115467","article-title":"1,8-cineole (eucalyptol): a versatile phytochemical with therapeutic applications across multiple diseases","volume":"167","author":"Hoch","year":"2023","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2025.118100_bib38","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejphar.2018.07.060","article-title":"1,8-cineol inhibits the Wnt\/beta-catenin signaling pathway through GSK-3 dephosphorylation in nasal polyps of chronic rhinosinusitis patients","volume":"835","author":"Bruchhage","year":"2018","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118100_bib39","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pupt.2004.06.002","article-title":"Inhibitory activity of 1,8-cineol (eucalyptol) on cytokine production in cultured human lymphocytes and monocytes","volume":"17","author":"Juergens","year":"2004","journal-title":"Pulm. Pharm. Ther."},{"key":"10.1016\/j.biopha.2025.118100_bib40","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1007\/s10753-016-0394-3","article-title":"1, 8-Cineol protect against influenza-virus-induced pneumonia in Mice","volume":"39","author":"Li","year":"2016","journal-title":"Inflammation"},{"key":"10.1016\/j.biopha.2025.118100_bib41","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s10753-013-9770-4","article-title":"1,8-cineol attenuates LPS-induced acute pulmonary inflammation in mice","volume":"37","author":"Zhao","year":"2014","journal-title":"Inflammation"},{"key":"10.1016\/j.biopha.2025.118100_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122746","article-title":"1.8-cineole prevents platelet activation and aggregation by activating the cAMP pathway via the adenosine A(2A) receptor","volume":"350","author":"Petry","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2025.118100_bib43","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1182\/bloodadvances.2021005210","article-title":"Upregulation of cAMP prevents antibody-mediated thrombus formation in COVID-19","volume":"6","author":"Zlamal","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.biopha.2025.118100_bib44","unstructured":"L. Christine (2023) Treat COVID-19 Patients With Regadenson. ed NCT04606069 (ClinicalTrials.gov)."},{"key":"10.1016\/j.biopha.2025.118100_bib45","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7155\/4\/2\/026006","article-title":"Real-time breath gas analysis for pharmacokinetics: monitoring exhaled breath by on-line proton-transfer-reaction mass spectrometry after ingestion of eucalyptol-containing capsules","volume":"4","author":"Beauchamp","year":"2010","journal-title":"J. Breath. Res"},{"key":"10.1016\/j.biopha.2025.118100_bib46","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1038\/s41598-023-29941-x","article-title":"Determination of orally administered 1,8-Cineol in nasal polyp tissues from chronic rhinosinusitis patients using gas chromatography: mass spectrometry","volume":"13","author":"MacKenzie","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118100_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.862522","article-title":"Persistent lung injury and prothrombotic state in long COVID","volume":"13","author":"Xiang","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2025.118100_bib48","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/s41586-021-03475-6","article-title":"The spatial landscape of lung pathology during COVID-19 progression","volume":"593","author":"Rendeiro","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118100_bib49","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature21706","article-title":"The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors","volume":"544","author":"Lefran\u00e7ais","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118100_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e21893","article-title":"SARS-CoV-2 activates the TLR4\/MyD88 pathway in human macrophages: a possible correlation with strong pro-inflammatory responses in severe COVID-19","volume":"9","author":"Sahanic","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.biopha.2025.118100_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2020.104587","article-title":"Immunoinformatics approach to understand molecular interaction between multi-epitopic regions of SARS-CoV-2 spike-protein with TLR4\/MD-2 complex","volume":"85","author":"Bhattacharya","year":"2020","journal-title":"Infect. Genet Evol."},{"key":"10.1016\/j.biopha.2025.118100_bib52","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/jmv.25987","article-title":"In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs","volume":"92","author":"Choudhury","year":"2020","journal-title":"J. Med Virol."},{"key":"10.1016\/j.biopha.2025.118100_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22030992","article-title":"Can SARS-CoV-2 virus use multiple receptors to enter host cells?","volume":"22","author":"Gadanec","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118100_bib54","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ijbiomac.2021.10.112","article-title":"SARS-CoV-2 spike protein causes blood coagulation and thrombosis by competitive binding to heparan sulfate","volume":"193","author":"Zheng","year":"2021","journal-title":"Int J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2025.118100_bib55","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1182\/blood.2021011871","article-title":"Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for platelets","volume":"138","author":"Bye","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2025.118100_bib56","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1080\/09537104.2022.2078489","article-title":"Tirofiban potentiates agonist-induced platelet activation and degranulation, despite effectively inhibiting aggregation","volume":"33","author":"Bucsai","year":"2022","journal-title":"Platelets"},{"key":"10.1016\/j.biopha.2025.118100_bib57","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1182\/bloodadvances.2022007444","article-title":"Platelet activation by SARS-CoV-2 implicates the release of active tissue factor by infected cells","volume":"6","author":"Puhm","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.biopha.2025.118100_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051037","article-title":"The P2Y12 antagonists, 2MeSAMP and cangrelor, inhibit platelet activation through P2Y12\/Gi-dependent mechanism","volume":"7","author":"Xiang","year":"2012","journal-title":"PLOS ONE"},{"key":"10.1016\/j.biopha.2025.118100_bib59","doi-asserted-by":"crossref","first-page":"16108","DOI":"10.1074\/jbc.M809780200","article-title":"The P2Y12 antagonists, 2-methylthioadenosine 5\u2032-monophosphate triethylammonium salt and cangrelor (ARC69931MX), can inhibit human platelet aggregation through a Gi-independent increase in cAMP levels","volume":"284","author":"Srinivasan","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118100_bib60","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1084\/jem.20022181","article-title":"Targeting platelet-leukocyte interactions: identification of the integrin Mac-1 binding site for the platelet counter receptor glycoprotein Ibalpha","volume":"198","author":"Ehlers","year":"2003","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.biopha.2025.118100_bib61","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1161\/01.ATV.20.12.2702","article-title":"Platelet-leukocyte cross talk in whole blood","volume":"20","author":"Li","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biopha.2025.118100_bib62","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1084\/jem.192.2.193","article-title":"Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b\/CD18)","volume":"192","author":"Simon","year":"2000","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.biopha.2025.118100_bib63","article-title":"Leukocyte integrin Mac-1 regulates thrombosis via interaction with platelet GPIb\u03b1","volume":"8","author":"Wang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.118100_bib64","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s10565-021-09693-y","article-title":"SARS-CoV-2 Spike protein is not pro-inflammatory in human primary macrophages: endotoxin contamination and lack of protein glycosylation as possible confounders","volume":"38","author":"Cinquegrani","year":"2022","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.biopha.2025.118100_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22147540","article-title":"Variable induction of pro-inflammatory cytokines by commercial SARS CoV-2 spike protein reagents: potential impacts of LPS on in vitro modeling and pathogenic mechanisms in vivo","volume":"22","author":"Ouyang","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118100_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgeb.2023.100347","article-title":"SARS-CoV-2 Omicron Spike shows strong binding affinity and favourable interaction landscape with the TLR4\/MD2 compared to other variants","volume":"22","author":"Chakraborty","year":"2024","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"10.1016\/j.biopha.2025.118100_bib67","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1182\/blood.2020008248","article-title":"Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition","volume":"136","author":"Yu","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2025.118100_bib68","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jacbts.2020.12.009","article-title":"Platelet and endothelial activation as potential mechanisms behind the thrombotic complications of COVID-19 patients","volume":"6","author":"Canzano","year":"2021","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.biopha.2025.118100_bib69","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1038\/s41467-022-32867-z","article-title":"Circulating multimeric immune complexes contribute to immunopathology in COVID-19","volume":"13","author":"Ankerhold","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.118100_bib70","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc8378","article-title":"Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity","volume":"371","author":"Larsen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.biopha.2025.118100_bib71","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood.2020008762","article-title":"Antibody-induced procoagulant platelets in severe COVID-19 infection","volume":"137","author":"Althaus","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2025.118100_bib72","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/jth.15587","article-title":"Antibody-mediated procoagulant platelet formation in COVID-19 is AKT dependent","volume":"20","author":"Pelzl","year":"2022","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.biopha.2025.118100_bib73","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jmii.2022.04.005","article-title":"Relationship between SARS-CoV-2 antibody titer and the severity of COVID-19","volume":"55","author":"Park","year":"2022","journal-title":"J. Microbiol Immunol. Infect."},{"key":"10.1016\/j.biopha.2025.118100_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/v15112250","article-title":"Longitudinal analysis of antibody response following SARS-CoV-2 infection depending on disease severity: a prospective cohort study","volume":"15","author":"Zirou","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.biopha.2025.118100_bib75","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.cell.2020.12.015","article-title":"COVID-19-neutralizing antibodies predict disease severity and survival","volume":"184","author":"Garcia-Beltran","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2025.118100_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.867716","article-title":"High titers of low affinity antibodies in COVID-19 patients are associated with disease severity","volume":"13","author":"Hendriks","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2025.118100_bib77","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/s41564-020-00789-5","article-title":"Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies","volume":"5","author":"Lee","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.biopha.2025.118100_bib78","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1182\/blood-2008-09-179754","article-title":"Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses","volume":"113","author":"Bruhns","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2025.118100_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065312","article-title":"SARS-CoV-2 Spike Protein and Neutralizing Anti-Spike Protein Antibodies Modulate Blood Platelet Function","volume":"24","author":"Luzak","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118100_bib80","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41577-022-00813-1","article-title":"Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection","volume":"23","author":"Zhang","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2025.118100_bib81","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1182\/blood.2020007252","article-title":"Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19","volume":"136","author":"Hottz","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2025.118100_bib82","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1182\/bloodadvances.2021006680","article-title":"Platelet-monocyte interaction amplifies thromboinflammation through tissue factor signaling in COVID-19","volume":"6","author":"Hottz","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.biopha.2025.118100_bib83","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1182\/blood.2020007008","article-title":"Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome","volume":"136","author":"Middleton","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2025.118100_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104950","article-title":"Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study","volume":"158","author":"Viecca","year":"2020","journal-title":"Pharm. Res"},{"key":"10.1016\/j.biopha.2025.118100_bib85","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1213\/ANE.0000000000005292","article-title":"Aspirin use is associated with decreased mechanical ventilation, intensive care unit admission, and in-hospital mortality in hospitalized patients with coronavirus disease 2019","volume":"132","author":"Chow","year":"2021","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.biopha.2025.118100_bib86","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1002\/jmv.27053","article-title":"Decreased in-hospital mortality associated with aspirin administration in hospitalized patients due to severe COVID-19","volume":"93","author":"Haji Aghajani","year":"2021","journal-title":"J. Med Virol."},{"key":"10.1016\/j.biopha.2025.118100_bib87","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ajh.26102","article-title":"Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: a propensity score-matched analysis","volume":"96","author":"Meizlish","year":"2021","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.biopha.2025.118100_bib88","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1177\/1358863X211012754","article-title":"Effect of aspirin on short-term outcomes in hospitalized patients with COVID-19","volume":"26","author":"Sahai","year":"2021","journal-title":"Vasc. Med"},{"key":"10.1016\/j.biopha.2025.118100_bib89","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ajem.2021.01.016","article-title":"Effect of antiplatelet treatments on patients with COVID-19 infection: a systematic review and meta-analysis","volume":"43","author":"Wang","year":"2021","journal-title":"Am. J. Emerg. Med"},{"key":"10.1016\/j.biopha.2025.118100_bib90","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/jama.2021.23605","article-title":"Effect of P2Y12 inhibitors on survival free of organ support among non-critically ill hospitalized patients with COVID-19: a randomized clinical trial","volume":"327","author":"Berger","year":"2022","journal-title":"Jama"},{"key":"10.1016\/j.biopha.2025.118100_bib91","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.thromres.2003.08.026","article-title":"Aspirin treatment does not attenuate platelet or leukocyte activation as monitored by whole blood flow cytometry","volume":"111","author":"Li","year":"2003","journal-title":"Thromb. Res"},{"key":"10.1016\/j.biopha.2025.118100_bib92","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/09537104.2016.1246713","article-title":"The effect of P2Y12 inhibition on platelet activation assessed with aggregation- and flow cytometry-based assays","volume":"28","author":"Leunissen","year":"2017","journal-title":"Platelets"},{"key":"10.1016\/j.biopha.2025.118100_bib93","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fimmu.2016.00123","article-title":"The cAMP pathway as therapeutic target in autoimmune and inflammatory diseases","volume":"7","author":"Raker","year":"2016","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2025.118100_bib94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0239692","article-title":"Therapeutic effects of adenosine in high flow 21% oxygen aereosol in patients with Covid19-pneumonia","volume":"15","author":"Correale","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118100_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0288920","article-title":"Regadenoson for the treatment of COVID-19: a five case clinical series and mouse studies","volume":"18","author":"Rabin","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118100_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e19226","article-title":"Improved survival of SARS COV-2-infected K18-hACE2 mice treated with adenosine A(2A)R agonist","volume":"9","author":"Mann","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.biopha.2025.118100_bib97","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1139\/y02-142","article-title":"Cardiovascular effects of 1,8-cineole, a terpenoid oxide present in many plant essential oils, in normotensive rats","volume":"80","author":"Lahlou","year":"2002","journal-title":"Can. J. Physiol. Pharm."},{"key":"10.1016\/j.biopha.2025.118100_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106151","article-title":"1,8-Cineole ameliorates right ventricle dysfunction associated with pulmonary arterial hypertension by restoring connexin43 and mitochondrial homeostasis","volume":"180","author":"Alves-Silva","year":"2022","journal-title":"Pharm. Res"},{"key":"10.1016\/j.biopha.2025.118100_bib99","first-page":"1495","article-title":"Acute and subacute toxicity study of 1,8-cineole in mice","volume":"7","author":"Xu","year":"2014","journal-title":"Int J. Clin. Exp. Pathol."},{"key":"10.1016\/j.biopha.2025.118100_bib100","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/infdis\/jiac136","article-title":"Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review","volume":"226","author":"Chen","year":"2022","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.biopha.2025.118100_bib101","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/eurheartj\/ehac031","article-title":"Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus","volume":"43","author":"Raman","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2025.118100_bib102","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/CIRCRESAHA.122.321659","article-title":"Persisting platelet activation and hyperactivity in COVID-19 survivors","volume":"131","author":"Martins-Gon\u00e7alves","year":"2022","journal-title":"Circ. Res"},{"key":"10.1016\/j.biopha.2025.118100_bib103","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/j.jtha.2023.04.039","article-title":"Thromboinflammation in long COVID-the elusive key to postinfection sequelae?","volume":"21","author":"Nicolai","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.biopha.2025.118100_bib104","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12933-021-01359-7","article-title":"Persistent clotting protein pathology in Long COVID\/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin","volume":"20","author":"Pretorius","year":"2021","journal-title":"Cardiovasc Diabetol."},{"key":"10.1016\/j.biopha.2025.118100_bib105","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1042\/BCJ20220016","article-title":"A central role for amyloid fibrin microclots in long COVID\/PASC: origins and therapeutic implications","volume":"479","author":"Kell","year":"2022","journal-title":"Biochem J."},{"key":"10.1016\/j.biopha.2025.118100_bib106","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/jmv.25936","article-title":"SARS-CoV-2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens","volume":"92","author":"Peng","year":"2020","journal-title":"J. Med Virol."},{"key":"10.1016\/j.biopha.2025.118100_bib107","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1038\/s41467-020-19057-5","article-title":"SARS-CoV-2 viral load is associated with increased disease severity and mortality","volume":"11","author":"Fajnzylber","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.118100_bib108","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0281052","article-title":"SARS-CoV-2 viremia and COVID-19 mortality: a prospective observational study","volume":"18","author":"Giacomelli","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118100_bib109","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2025.118100_bib110","article-title":"SARS-CoV-2 infects endothelial cells in vivo and in vitro","volume":"11","author":"Liu","year":"2021","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.biopha.2025.118100_bib111","article-title":"Extracellular vesicles carry SARS-CoV-2 spike protein and serve as decoys for neutralizing antibodies","volume":"10","author":"Troyer","year":"2021","journal-title":"J. Extra Vesicles"},{"key":"10.1016\/j.biopha.2025.118100_bib112","article-title":"Exosomes recovered from the plasma of COVID-19 patients expose SARS-CoV-2 spike-derived fragments and contribute to the adaptive immune response","volume":"12","author":"Pesce","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2025.118100_bib113","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41421-022-00510-2","article-title":"Extracellular vesicles mediate antibody-resistant transmission of SARS-CoV-2","volume":"9","author":"Xia","year":"2023","journal-title":"Cell Discov."},{"key":"10.1016\/j.biopha.2025.118100_bib114","article-title":"Extracellular vesicle-mediated endothelial apoptosis and EV-associated proteins correlate with COVID-19 disease severity","volume":"10","author":"Krishnamachary","year":"2021","journal-title":"J. Extra Vesicles"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222500294X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222500294X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T19:57:23Z","timestamp":1759003043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222500294X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":114,"alternative-id":["S075333222500294X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118100","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-CoV-2 S1 protein induces IgG-mediated platelet activation and is prevented by 1.8-cineole","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118100"}}